Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Septicemia during compromised host treated in a protected isolation unit.

T Nagao, K Watanabe, M Komatsuda

    The Tokai Journal of Experimental and Clinical Medicine
    |January 1, 1980
    PubMed
    Summary

    Patients undergoing chemotherapy and experiencing leukopenia may develop septicemia after stopping oral antibiotics. Parenteral antibiotics are crucial in protected isolation units to prevent severe outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of the Isolated Nuclear Two-Photon Decay in ^{72}Ge.

    Physical review letters·2024
    Same author

    First Application of Mass Measurements with the Rare-RI Ring Reveals the Solar r-Process Abundance Trend at A=122 and A=123.

    Physical review letters·2022
    Same author

    Swelling of Doubly Magic ^{48}Ca Core in Ca Isotopes beyond N=28.

    Physical review letters·2020
    Same author

    First Direct Mass Measurements of Nuclides around Z=100 with a Multireflection Time-of-Flight Mass Spectrograph.

    Physical review letters·2018
    Same author

    Evidence for prevalent Z = 6 magic number in neutron-rich carbon isotopes.

    Nature communications·2018
    Same author

    High repetition pump-and-probe photoemission spectroscopy based on a compact fiber laser system.

    The Review of scientific instruments·2017

    Area of Science:

    • Infectious Diseases
    • Hematology
    • Immunology

    Background:

    • Septicemia poses a significant risk in immunocompromised patients, particularly those undergoing chemotherapy.
    • Leukopenia and immunodeficiency following chemotherapy create a vulnerable state for infection.
    • Protected isolation units are used to manage high-risk patients but require specific infection control protocols.

    Purpose of the Study:

    • To evaluate bacteriological, hematological, and immunological data in patients with septicemia in a protected isolation unit.
    • To assess the impact of antimicrobial prophylaxis on septicemia episodes.
    • To determine optimal antibiotic strategies post-chemotherapy in this patient population.

    Main Methods:

    • Retrospective analysis of bacteriological, hematological, and immunological data.

    Related Experiment Videos

  • Evaluation of septicemia episodes in patients receiving antimicrobial prophylaxis.
  • Correlation of septicemia occurrence with chemotherapy-induced leukopenia and immunodeficiency.

    • Main Results:

    • Three out of four septicemia episodes occurred 2-4 days after discontinuing oral non-absorbed antibiotics during chemotherapy-induced leukopenia.
    • Two patients with non-recovering white blood cell counts died within 10 days.
    • Septicemia was suppressed in other patients, with one achieving complete remission.

    Conclusions:

    • Discontinuation of oral prophylactic antibiotics requires careful consideration in immunocompromised patients.
    • Parenteral antibiotic administration is necessary after stopping oral prophylaxis in protected isolation units.
    • Prompt and appropriate antibiotic therapy is critical for managing septicemia in high-risk patients.